According to the announcement by Heavy Pharmaceutical Holdings, the holding subsidiary of the company, Chongqing Pharmaceutical Co., Ltd. plans to register to issue perpetual notes, with a registered issuance scale of no more than 2.4 billion yuan. Ultimately, the amount accepted for registration by the China Interbank Market Dealers Association shall prevail. The basic term of this perpetual note is not more than 5 years. It can be issued once or in installments using public or non-public issuance methods. The funds raised are intended to be used for purposes that comply with laws and regulations, such as paying off interest-bearing liabilities and supplementing working capital. The matter still needs to be submitted to the company's shareholders' meeting for consideration and reported to the relevant competent department for approval before it can be implemented.

According to the announcement by Heavy Pharmaceutical Holdings, the holding subsidiary of the company, Chongqing Pharmaceutical Co., Ltd. plans to register to issue perpetual notes, with a registered issuance scale of no more than 2.4 billion yuan. Ultimately, the amount accepted for registration by the China Interbank Market Dealers Association shall prevail. The basic term of this perpetual note is not more than 5 years. It can be issued once or in installments using public or non-public issuance methods. The funds raised are intended to be used for purposes that comply with laws and regulations, such as paying off interest-bearing liabilities and supplementing working capital. The matter still needs to be submitted to the company's shareholders' meeting for consideration and reported to the relevant competent department for approval before it can be implemented.